WO1993019162A1 - Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality - Google Patents

Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality Download PDF

Info

Publication number
WO1993019162A1
WO1993019162A1 PCT/US1993/000867 US9300867W WO9319162A1 WO 1993019162 A1 WO1993019162 A1 WO 1993019162A1 US 9300867 W US9300867 W US 9300867W WO 9319162 A1 WO9319162 A1 WO 9319162A1
Authority
WO
WIPO (PCT)
Prior art keywords
direct
fatty acid
fed microbial
feed
fed
Prior art date
Application number
PCT/US1993/000867
Other languages
French (fr)
Inventor
William M. Rutherford
Jack E. Allen
Scott M. Dennis
Mark A. Hinds
Gregory R. Dana
Original Assignee
Pioneer Hi-Bred International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pioneer Hi-Bred International, Inc. filed Critical Pioneer Hi-Bred International, Inc.
Priority to RU94043791A priority Critical patent/RU2109052C1/en
Priority to EP93904784A priority patent/EP0631616A4/en
Priority to SK1116-94A priority patent/SK111694A3/en
Priority to BR9306121A priority patent/BR9306121A/en
Priority to RO94-01518A priority patent/RO112896B1/en
Publication of WO1993019162A1 publication Critical patent/WO1993019162A1/en
Priority to BG99113A priority patent/BG99113A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Definitions

  • Growth enhancers in the form of antibiotics have been used extensively for poultry, namely chickens and turkey.
  • Growth enhancers such as Stafac ® and BMD ® (bacitracin methylene disalicylate) are known.
  • antibiotics and have been used at sub-therapeutic levels of for example, 10 grams per ton and 25 grams per ton as feed additives in order to promote
  • Direct-fed microbials do have some difficulty in maintaining a stable product.
  • the direct-fed microbial is used at a fairly low level, added to feed at perhaps a 0.1% level.
  • unused direct-fed microbial containing feed or feed additive product is often stored by the farmers for long periods of time. This storage many times is under conditions where there is some moisture and high temperature. In many instances there is just enough moisture that the bacteria are activated or start to grow, but yet there is an insufficient amount of moisture to sustain them. As a result they die. Thus, the activity of the direct-fed microbial is stopped. In other instances, the
  • Uniformity of flock weight is important because if more birds are normal in size, less hand labor is required and processors can more extensively rely on machine processing. On the other hand, if the birds vary considerably from very small birds to very large birds, even though the overall flock weight may be the same, the smaller birds and the larger birds require a great deal more hand labor and because of their lack of uniformity in size, cannot be processed easily by machine. Thus, uniformity of flock weight with a high percentage distribution within the normal size range so that chickens can process by standardized machinery is a desirable feature.
  • invention to provide a direct-fed microbial which, for poultry, provides increased rate of weight gain, which provides better feed conversion, which provides higher yield of breast meat, and which provides for
  • An even further primary objective of the present invention is to provide direct-fed microbials suitable for poultry feed ration addition which contains bacteria that are in microsphere form using a special rotary technique using free fatty acid matrix.
  • Another objective of the present invention is to provide a direct-fed microbial which has stability at levels within the range of from 3 months to 6 months without any significant organism count reduction.
  • Another objective of the present invention is to provide a process of rotary formation of spheres containing the dried bacteria which provides having uniform size.
  • Another objective of the present invention is to provide rotary disc spheres of dried bacteria which are free flowing, and easily processable with poultry feed rations.
  • a still further objective is to provide a
  • microsphere of fatty acid material containing certain bacteria with spheres being useful as a direct-fed microbial for both poultry and swine.
  • Figures 1, 2 and 3 show graphically the stability of the strains using stearic acid matrix.
  • Figure 4 is a graph showing breast yield
  • Figure 5 is a graph showing body weight
  • Figures 4 and 5 show a control, use of an
  • the invention is a method and composition of growth promotion for poultry and swine which comprises adding to the normal feed ration a small but growth promoting effective amount of a direct-fed microbial which contains dried, fatty acid microspheres of
  • Enterococcus faecium 301 DSM No. DSM-Nr. 4789, and dried fatty acid microspheres of Enterococcus faecium 202, DSM No. DSM-Nr. 4788, where preferably the fatty microspheres are formed by rotary disc drying.
  • a fatty acid employed may be any one of the C 12 to C 24 free fatty acids, but is preferably stearic acid.
  • the organisms are preferably present in about equal amounts but may vary within the range from about 30% to about 70% of one of the organisms with the balance being the other.
  • the amount of direct-fed microbial added to the feed ration can vary considerably but generally will be within the range of from about 0.5 pounds to about 2.0 pounds per ton of feed, generally from about 0.8 pounds to about 1.2 pounds per ton of feed, and typically at about 1 pound per ton of feed.
  • the organism count, that is the number of colony forming units per gram present in the direct-fed microbial can also vary within the range of from about 1 ⁇ 10 6
  • CFU/gm to about 2 ⁇ 10 9 CFU/gm, but is preferably at about 2 ⁇ 10 8 CFU/gm.
  • Stafac ⁇ and BMD The advantages of sub-therapeutic levels of antibiotics as growth promoting additives can be achieved with naturally occurring organisms of the present invention provided that direct-fed
  • microbial is made in accordance with the present invention and added in accordance with the method described herein.
  • a combination of direct-fed microbial and growth promotant together exceeds the advantages of either alone and thus they may be used together if desired.
  • the method of processing of the organisms is not critical as long as the organisms can be kept alive to delivery to the animal, and placed in a form so that it will combine with animal feed well and is of a generally uniform size so that dosage may be
  • a microsphere refers to a fatty acid matrix in which a plurality of organisms is incorporated. It is different from a microcapsule in which individual organisms are each encapsulated. In a microsphere the fatty acid matrix functions for the composite similar to the
  • microspheres are formed wherein each sphere constitutes a plurality of bacteria in a free fatty acid matrix rather than an individual
  • microencapsulator of each bacteria in a coating or film like layer of fatty acid This provides
  • the preferred matrix agent is a C 12 to C 24 free fatty acid. While mixtures of fatty acids may be employed, it is preferred that a single pure free fatty acid be employed. It is also preferred that the free fatty acid be an unsaturated fatty acid, with the most preferred being stearic acid.
  • the fatty acid have a melting point less than 75oC, preferably within the range of 40°C to 75°C. It must, of course, be solid at room temperature in order to be an effective matrix. All free fatty acids falling within the range of chemical description heretofore given will meet these requirements.
  • the bacteria are typically freeze-dried bacteria as placed in the product. Thus, they can be revived by moisture addition.
  • the microspheres generally comprise from about 50% to over 90% by weight of the fatty acid component with the balance being bacterial culture.
  • the preferred range is from about 60% to about 75% fatty acid. If too little fatty acid is used, the matrix will be inadequate for protection. On the other hand, if too much is used, the matrix will be too thick and results in inadequate release in the gut.
  • the process as used in this invention is a rotary disc microsphere formation process.
  • a slurry of the bacteria and fatty acid components are thoroughly mixed with the mixture being added at a uniform rate onto the center of a rotating stainless steel disc. It is there flung outwardly as a result of centrifugal force and forms a microsphere. It is then collected in a cooling chamber maintained at ambient conditions or slightly lower, sized and readied for packaging.
  • microencapsulation In conventional tower spray drying there is a tendency for particles to cluster, for the coating to be uneven, and thus for the
  • the rotary disk typically employing a 4"-6" rotary disc
  • the rotary disk can be run at the rate of from 2000 rpm to 4000 rpm, preferably about 2500 rpm to 3200 rpm with a feed rate of from 50 grams to 200 grams per minute.
  • the preferred conditions presently known are use of stearic acid, use of two hereinbefore described organisms, a four inch rotary disc, 3000 rpm and a feed rate of 100 grams per minute with a bacteria/stearic acid slurry of 35% bacteria, 65% stearic acid.
  • a product having a particle size of from 75 microns to 300 microns will be achieved, with a preferred level of less than 250 microns.
  • Example 1 through 4 and Figures 1, 2, and 3 relate to the invention of my prior case.
  • Example 5, and tables 2-10 relate to the process of this present invention for a poultry direct-fed microbial.
  • Example 6 relates to turkeys specifically and example 7 relates to swine.
  • Example 1 correlates with Figure 1. It shows the product stability of two different strains of
  • Enterococcus faecium with temperatures of 4°C and 27 oC.
  • Figure 1 shows a stability of the encapsulated strains of Enterococcus faecium, with the encapsulation being by the rotary disc device using stearic acid with a level of 35% culture weight.
  • Conditions of microsphere formation were as previously described herein, namely a 35/65 bacteria stearic acid slurry at a temperature of 60 °C, using a four inch rotary disc, operating at 3000 rpm and a feed rate of 100 grams per minute.
  • the spheres were formed, placed in heat sealed vapor barrier pouches and destructively sampled weekly for CFU determination. It can be seen that the product of the invention maintained excellent organism colony forming unit (CFU) counts out to storage times at long as 70 days.
  • CFU colony forming unit
  • Example 2 is to be interpreted in connection with Figure 2.
  • the figure shows the stability of
  • Example 3 is to be interpreted in conjunction with Figure 3. It shows the stability of the
  • Table 1 is a list of the minimum times for a 1 log loss in colony forming units (CFU). Table 1
  • Example 4 the stability of product after pelletizing for use of a chicken feed product was determined.
  • the microsphere formation conditions were as earlier described.
  • the conditions used in this study were the following:
  • Conditioning temperature was 70"C and the pellets out of the dye were 78 °C.
  • Pellets were stored in unsealed bags and sampled weekly for CFU determination.
  • the pelletized product was not adversely affected in stability by the conditions of pelletizing.
  • the pelletized product showed stability equal to the unpelletized product.
  • Starter, grower, and withdrawal rations were formulated to contain 1425, 1450, and 1475 kcal ME/lb, respectively, with 90 g/ton monesin. Starter rations were fed from 1 to 21 days of age, grower from 21 to 42 days of age, and withdrawal from 42 to 49 days of age. The
  • each rotary disc fatty acid encapsulated as described in Example 1 and ed n. present as 50% of the direct-fed microbial applied at 1 ⁇ 10 5 CFU/g of feed, mash (direct-fed microbial, M); negative control, pelleted (Control, P); direct-fed microbial applied at 1 ⁇ 10 6 CFU/g mash, pelleted (direct-fed microbial, P); and a positive control applied at 10 g/ton
  • a mixer test was conducted for each production phase. The test was designed to ensure that the direct-fed microbial was uniformly distributed at appropriate levels in the feed and that it survived pelleting. Each batch was sampled at the time of bagging with 4 equally spaced samples for the mash treatments and 10 equally spaced samples for the pelleted treatments (i.e. bags 1, 3, 5,..., 35, 37, and 39).
  • Alternate floor pens within a treatment had non-contaminated feed sampled during weeks 1 and 4; with the remaining pens sampled on weeks 2 and 6 during the feeding study.
  • Direct-fed microbial regardless of processing, improved ( P ⁇ .05 ) feed conversion over the respective Control while increasing (P ⁇ .05) weight gain over the Control only in the mash feed (Table 4).
  • the product was at its desired level and strain composition (Table 5).
  • Direct-fed microbial was uniformly distributed within the feed. Direct-fed microbial, M was at its desired level while direct-fed microbial, P was 1 to 1-1/2 log higher than desired for the starter and grower rations (Table 6). The high counts for direct-fed microbial, P were a result of overengineering of the product to ensure sufficient recovery of the organisms after pelleting.
  • the direct-fed microbial treatments produced a shorter (P>.05) small intestinal length than either of the Controls and Stafac ® when expressed as actual length, a ratio of either body weight, or breast weight (Table 9).
  • Direct-fed microbial, M had a lighter (P>.05) small intestinal weight than Control, M when expressed as either actual weight or percentage of either body or breast weights.
  • the reduction in intestinal weight and length for direct-fed microbial treatments suggests less energy required for
  • Mecadox ® 50 g/t up through 75 lb bodyweight followed by 100 g/t
  • the commingled feeder pigs were given Ivomec ® to control internal and external parasites.
  • Safeguard ® was given after four weeks to control whipworms. Body weights, feed consumption, and mortality were recorded by pen. Feed conversion was calculated for each pen.
  • microsphere culture concentrate Prior to the study, the microsphere culture concentrate was extended with calcium carbonate. The theoretical count was 2 ⁇ 10 7 cfu/g of product. An 11 g sample of product was assayed in duplicate to determine actual product counts. The sample was plated using standard plating technique for
  • microsphered lactic acid bacteria microsphered lactic acid bacteria.
  • Pen sample recoveries varied from 1 ⁇ 10 1 to 1.6 ⁇ 10 5 cfu/g of feed (Table 15). The two extreme samples are attributed to sampling/plating error. The remainder of the samples averaged around the target level of 1 ⁇ 10 4 cfu/g of feed.
  • Microsphered product improved (P>.05) weight gain and feed conversion over the Control after 28 days
  • Pen size 4.6' x 16.0', one four-hole Smidley feeder, one nipple driker, sprinklers were used for heat control, partially-slated floor, and modified, open-front building.

Abstract

Dried, rotary disc fatty acid microspheres of Enterococcus faecium, strains 301 and 202 are mixed and used as a feed additive for animals for growth enhancement and carcass quality improvement.

Description

Title: FATTY ACID MICROSPHERES CONTAINING
ENTEROCOCCUS FOR USE TO ENHANCE GROWTH AND IMPROVE CARCASS QUALITY
BACKGROUND OF THE INVENTION
Growth enhancers in the form of antibiotics have been used extensively for poultry, namely chickens and turkey. Growth enhancers such as Stafac ® and BMD ® (bacitracin methylene disalicylate) are known
antibiotics and have been used at sub-therapeutic levels of for example, 10 grams per ton and 25 grams per ton as feed additives in order to promote
desirable growth features in poultry. However, the use of antibiotics for these purposes has recently come under some criticism. One of the criticisms is the possibility that the poultry eventually develop tolerance to the antibiotics and eventually the antibiotic no longer works well for growth promotion. Other objections relate to health concerns from non-natural antibiotic additives and the adulterating effects they may have. Nevertheless, because of the advantages of antibiotic uses they are still commonly used in order to improve feed conversion, improve carcass composition, and enhance growth.
It is known that certain bacteria are potentially beneficial when added to animal feeds. These bacteria are beneficial in that they supply a natural
intestinal micro-flora. Some companies offer for sale direct-fed microbials which contain desirable
bacteria. Direct-fed microbials, however, do have some difficulty in maintaining a stable product.
Typically, the direct-fed microbial is used at a fairly low level, added to feed at perhaps a 0.1% level. However, unused direct-fed microbial containing feed or feed additive product is often stored by the farmers for long periods of time. This storage many times is under conditions where there is some moisture and high temperature. In many instances there is just enough moisture that the bacteria are activated or start to grow, but yet there is an insufficient amount of moisture to sustain them. As a result they die. Thus, the activity of the direct-fed microbial is stopped. In other instances, the
addition of antibiotics to the direct-fed microbial containing feed or feed additive adversely interacts with the bacteria, particularly if there are small amounts of moisture present and thus again bacteria are killed. Thus, there is a significant problem of long term storage stability for direct-fed microbials.
In another environment, where the direct-fed microbial is added to, for example chicken feed, it is common to pelletize the material with the direct-fed microbial added before pelletizing. Moisture from steam used during pelletization partially activates the bacteria, but may, as a result of insufficient moisture to sustain them, kill them. Also heat during pelletization may kill them. Then, too, there is the problem of the acid environment of the stomach
potentially inactivating bacteria before they really reach the intestine. Thus, there is a continuing need for direct-fed microbials which will release the organisms only at the proper time in the intestine, without early release due to moisture conditions or adverse pH conditions such as exist in the digestive tract anterior to the small intestine. Certain features of poultry are especially desirable to achieve if possible. Those include an increased rate of weight gain, better feed conversion, carcass composition, and finally uniformity of flock weight. Increased rate of weight gain and better feed conversion are, of course, desirable for the attendant economics that accompany these desirable results. The composition of carcass is important because the most desirable area for tissue deposit is the breast in order to yield a high amount of choice meat. Thus, weight gain is not only important, but where the weight is gained on the carcass is also important.
Uniformity of flock weight is important because if more birds are normal in size, less hand labor is required and processors can more extensively rely on machine processing. On the other hand, if the birds vary considerably from very small birds to very large birds, even though the overall flock weight may be the same, the smaller birds and the larger birds require a great deal more hand labor and because of their lack of uniformity in size, cannot be processed easily by machine. Thus, uniformity of flock weight with a high percentage distribution within the normal size range so that chickens can process by standardized machinery is a desirable feature.
Similarly, a direct-fed microbial which is not only useful for poultry, such as chickens and turkeys, but also useful for swine would be highly beneficial.
It is a primary objective of the present
invention to provide a poultry direct-fed microbial which contains no antibiotics and contains only fatty acid microspheres containing naturally occurring organisms. It is another primary objective of the present invention to provide a direct-fed microbial which contains two organisms, namely Enterococcus faecium 301, DSM No. DSM-Nr. 4789, and Enterococcus faecium 202, DSM No. DSM-Nr. 4788. DSM is a Bacterial Culture collection in Germany. DMS stands for Deutsche
Sammlung von Mikroorganismen located in Braunschweig, West Germany. These organisms will be deposited at the ATCC, with all restrictions lifted upon notice of allowable claims.
It is a further objective of the present
invention to provide a direct-fed microbial which, for poultry, provides increased rate of weight gain, which provides better feed conversion, which provides higher yield of breast meat, and which provides for
uniformity of flock weight within the range of normal size.
An even further primary objective of the present invention is to provide direct-fed microbials suitable for poultry feed ration addition which contains bacteria that are in microsphere form using a special rotary technique using free fatty acid matrix.
Another objective of the present invention is to provide a direct-fed microbial which has stability at levels within the range of from 3 months to 6 months without any significant organism count reduction.
Another objective of the present invention is to provide a process of rotary formation of spheres containing the dried bacteria which provides having uniform size.
Another objective of the present invention is to provide rotary disc spheres of dried bacteria which are free flowing, and easily processable with poultry feed rations. A still further objective is to provide a
microsphere of fatty acid material containing certain bacteria, with spheres being useful as a direct-fed microbial for both poultry and swine.
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1, 2 and 3 show graphically the stability of the strains using stearic acid matrix.
Figure 4 is a graph showing breast yield
distribution for a feeding trial of the direct-fed microbial composition of the present invention.
Figure 5 is a graph showing body weight
distribution for a feeding trial of the direct-fed microbial composition of the present invention.
Figures 4 and 5 show a control, use of an
antibiotic and use of the direct-fed microbial of the present invention.
SUMMARY OF THE INVENTION
The invention is a method and composition of growth promotion for poultry and swine which comprises adding to the normal feed ration a small but growth promoting effective amount of a direct-fed microbial which contains dried, fatty acid microspheres of
Enterococcus faecium 301, DSM No. DSM-Nr. 4789, and dried fatty acid microspheres of Enterococcus faecium 202, DSM No. DSM-Nr. 4788, where preferably the fatty microspheres are formed by rotary disc drying.
DETAILED DESCRIPTION OF THE INVENTION
It has been surprisingly discovered that the growth promotion of poultry and swine can be
accomplished by adding to normal feed rations, a certain amount of fatty acid microspheres of
Enterococcus faecium 301, DSM No. DSM-Nr. 4789, and a certain amount of fatty acid microspheres of
Enterococcus faecium 202, DSM No. DSM-Nr. 4788. A fatty acid employed may be any one of the C12 to C24 free fatty acids, but is preferably stearic acid. The organisms are preferably present in about equal amounts but may vary within the range from about 30% to about 70% of one of the organisms with the balance being the other.
It is not known precisely why these two organisms provide the desirable features of the present
invention, especially for poultry, namely increased rate of weight gain, better feed conversion, increased yield of breast meat, and increased uniformity of flock weight. The fact is that they do, provided that both are used in combination so that they can somehow interact with each other, and providing that they are used within the range herein expressed. It is these combinations of features which some how interact and co-act to provide the desirable features of the present invention which allow significantly improved poultry carcass, meat quality and processing. Similar results can be achieved for swine as indicated by the examples.
The amount of direct-fed microbial added to the feed ration can vary considerably but generally will be within the range of from about 0.5 pounds to about 2.0 pounds per ton of feed, generally from about 0.8 pounds to about 1.2 pounds per ton of feed, and typically at about 1 pound per ton of feed. The organism count, that is the number of colony forming units per gram present in the direct-fed microbial can also vary within the range of from about 1 × 106
CFU/gm to about 2 × 109 CFU/gm, but is preferably at about 2 × 108 CFU/gm.
When the direct-fed microbial as previously described is free choice fed in the animal feed ration, the combination of two strains of organisms herein mentioned, behave as a growth promoter. Growth promoters now used include antibiotics such as
Stafac© and BMD. The advantages of sub-therapeutic levels of antibiotics as growth promoting additives can be achieved with naturally occurring organisms of the present invention provided that direct-fed
microbial is made in accordance with the present invention and added in accordance with the method described herein. In fact, there have been some trials that suggest that a combination of direct-fed microbial and growth promotant together exceeds the advantages of either alone and thus they may be used together if desired. However, in most instances, it is preferred to use the direct-fed microbial alone since one of the objectives of the present invention is to avoid use of growth promotants altogether.
The method of processing of the organisms is not critical as long as the organisms can be kept alive to delivery to the animal, and placed in a form so that it will combine with animal feed well and is of a generally uniform size so that dosage may be
controlled.
A preferable means of achieving these
requirements is by providing the organisms in a microsphere of a fatty-acid matrix. A microsphere refers to a fatty acid matrix in which a plurality of organisms is incorporated. It is different from a microcapsule in which individual organisms are each encapsulated. In a microsphere the fatty acid matrix functions for the composite similar to the
relationship between a cookie dough matrix and
chocolate chips, with the chips representing the groups of organisms. This process is described in the parent application of the co-inventor Rutherford, et al. By this process, the bacteria are combined with a heated fatty acid. The temperature of the fatty acid and time of exposure of the bacteria to the fatty acid is controlled to keep the bacteria alive, yet allow mixing with the fatty acid. The mixture is placed on a rotating rotary disk, with the result being a microsphere of bacteria with a fatty acid acting as the matrix. Several important advantages are achieved using this method. First, the bacteria are kept alive through the processing; second, the process combined with the rotary disk technique allows for a uniform size of the microsphere for improved dosing. Third, the nature of the matrix, a fatty acid, allows the formation of the unique microspheres. The combination of the factors provides for a highly stable direct-fed microbial with maximum effectiveness.
In the process of the parent application it is important to note microspheres are formed wherein each sphere constitutes a plurality of bacteria in a free fatty acid matrix rather than an individual
microencapsulator of each bacteria in a coating or film like layer of fatty acid. This provides
stability advantages, and more effective dosing with the bacterial treatment.
The preferred matrix agent is a C12 to C24 free fatty acid. While mixtures of fatty acids may be employed, it is preferred that a single pure free fatty acid be employed. It is also preferred that the free fatty acid be an unsaturated fatty acid, with the most preferred being stearic acid.
Generally speaking, it is important that the fatty acid have a melting point less than 75ºC, preferably within the range of 40°C to 75°C. It must, of course, be solid at room temperature in order to be an effective matrix. All free fatty acids falling within the range of chemical description heretofore given will meet these requirements.
In order to enhance the product stability, the bacteria are typically freeze-dried bacteria as placed in the product. Thus, they can be revived by moisture addition.
In the microsphere, made in accordance with the process discussed below, the microspheres generally comprise from about 50% to over 90% by weight of the fatty acid component with the balance being bacterial culture. The preferred range is from about 60% to about 75% fatty acid. If too little fatty acid is used, the matrix will be inadequate for protection. On the other hand, if too much is used, the matrix will be too thick and results in inadequate release in the gut.
The process as used in this invention is a rotary disc microsphere formation process. Generally
speaking in the rotary disc technology, a slurry of the bacteria and fatty acid components are thoroughly mixed with the mixture being added at a uniform rate onto the center of a rotating stainless steel disc. It is there flung outwardly as a result of centrifugal force and forms a microsphere. It is then collected in a cooling chamber maintained at ambient conditions or slightly lower, sized and readied for packaging.
While rotary disc encapsulation per se is known, it is not known to make microspheres contained in a matrix without a surrounding shell, nor is it known to use the microsphere process or encapsulation with freeze dried bacteria. Generally speaking, for descriptions of rotary disc encapsulation, see a paper by Johnson, et al. of the Southwest Research Institute of San Antonio, in the Journal of Gas Chromotography, October, 1965, pages 345-347. In addition, a rotary disc machine suitable for use in this invention is described in detail in United States Letters Patent, Sparks, 4,675,140, issued June 23, 1987 and entitled "Method For Coating Particles For Liquid Droplets" the disclosure of which is incorporated herein by reference. However, it is the process described in the parent application that is most preferred.
It is important to note that rotary microsphere formation provides a distinctly different product than either conventional tower spray drying or
microencapsulation. In conventional tower spray drying there is a tendency for particles to cluster, for the coating to be uneven, and thus for the
stability of the product to be significantly effected perhaps from days to weeks. This process provides a shell coating around an object, and bacteria have proven to be too small, too hard to keep alive or provide in a uniform size to be of practical
usefulness. With microsphere formation, particularly with agents used in this invention is used, the stability of the resulting bacteria, even when
subjected to some moisture and antibiotics, will be for from three to six months with the viability of the bacteria maintained in evenly distributed particles.
When the free fatty acid microspheres of the present invention are used within the ranges
hereinbefore expressed, the rotary disk, typically employing a 4"-6" rotary disc, can be run at the rate of from 2000 rpm to 4000 rpm, preferably about 2500 rpm to 3200 rpm with a feed rate of from 50 grams to 200 grams per minute. The preferred conditions presently known are use of stearic acid, use of two hereinbefore described organisms, a four inch rotary disc, 3000 rpm and a feed rate of 100 grams per minute with a bacteria/stearic acid slurry of 35% bacteria, 65% stearic acid. When this is done, a product having a particle size of from 75 microns to 300 microns will be achieved, with a preferred level of less than 250 microns.
The following examples are offered to further illustrate, but not limit, the process of the present invention. Some of the examples are described in connection with Figures 1, 2 and 3. Examples 1 through 4 and Figures 1, 2, and 3 relate to the invention of my prior case. Example 5, and tables 2-10, relate to the process of this present invention for a poultry direct-fed microbial. Example 6 relates to turkeys specifically and example 7 relates to swine.
Example 1
Example 1 correlates with Figure 1. It shows the product stability of two different strains of
Enterococcus faecium with temperatures of 4°C and 27 ºC. As illustrated in Figure 1, it shows a stability of the encapsulated strains of Enterococcus faecium, with the encapsulation being by the rotary disc device using stearic acid with a level of 35% culture weight. Conditions of microsphere formation were as previously described herein, namely a 35/65 bacteria stearic acid slurry at a temperature of 60 °C, using a four inch rotary disc, operating at 3000 rpm and a feed rate of 100 grams per minute. The spheres were formed, placed in heat sealed vapor barrier pouches and destructively sampled weekly for CFU determination. It can be seen that the product of the invention maintained excellent organism colony forming unit (CFU) counts out to storage times at long as 70 days.
Example 2
Example 2 is to be interpreted in connection with Figure 2. The figure shows the stability of
individual microsphered strains when mixed in a typical feed ration in the presence of three poultry antibiotics. The ration consisted of the following:
54% fine cracked corn
26% soybean meal
2% fish meal
1.5% dicalcium phosphate
1% limestone
5.5% soy oil
12% moisture content
Three antibiotics were added at the following
inclusion rates by weight: decoquinoate 6% (454 ppm), salinomycin (50 ppm) and monensin sodium (120 ppm).
Culture was added to the mixture at a level to deliver approximately 1×106 CFU/gm feed. Feed was packaged in heat sealed bags and incubated at room temperature. Samples were taken weekly for CFU determination. The graph of Figure 2 illustrates the excellent stability.
Example 3
Example 3 is to be interpreted in conjunction with Figure 3. It shows the stability of the
Enterococcus faecium microspheres in feed in the presence of different antibiotics. The ration
consisted of 60% fine cracked corn, 38% soybean meal and 2% limestone with a moisture content of about 14%. Culture was added to a level of approximately 10
CFU/gm feed and mixed. Ten pound aliquots were stored in sealed bags at 20° C and sampled weekly for 16 weeks. The antibiotics were included in the ration at the following levels:
Bacitracin methylene disalicylate .. . . . 50 gm/ton
Carbadox .... . . ...... .... .. .. .... .. .. .... ........ ...... .. ....... . .. 50 gm/ton
Chlortetracycline . . . . . . . . . . . . . . . . . . . .200 gm/tom
Lasalocid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30 gm/ton
Lincomycin . . . . . . . . . . . . . . . . . . . . . . . . . . .100 gm/ton
Neomycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .140 gm/ton
Oxytetracycline . . . . . . . . . . . . . . . . . . . . . .150 gm/ton
Sulfamethazine . . . . . . . . . . . . . . . . . . . . . . .100 gm/ton
Tylosin . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..100 gm/ton
Virginiamycin . . . . . . . . . . . . . . . . . . . . . . . . .20 gm/ton
ASP250 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 gm/ton
Furadox . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .10 gm/ton
Table 1 is a list of the minimum times for a 1 log loss in colony forming units (CFU). Table 1
Time in weeks for loss of 1 log CFU counts
at 20°C in 14% moisture mash feed.
Antibiotic Time of Storaσe (days)
Control 103
Bacitracin 88
Carbadox 54
Chlortetracycline 60
Lasalocid 57
Lincomycin 75
Neomycin 53
Oxytetracycline 59
Sulfamethazine 62
Tylosin 52
Vxrginiamycin 112
ASP250 67
Furadox 53
Example 4
In Example 4 the stability of product after pelletizing for use of a chicken feed product was determined. The microsphere formation conditions were as earlier described. The conditions used in this study were the following:
Crude Protein, not less than .... . . . . .. . . .. . . . 18.0%
Crude Fat, not less than .... . . . . .. . . .. . . . . . .. .5.0%
Crude Fiber, not more than .... . . . . .. . . .. . . . . . .6.0%
The pellets with and without the antibiotic (CTC
50 gm/ton) were made with the following ingredients and conditions.
Corn, SBM, whey, soy oil, dicalcium phosphate, limestone, trace mineral premix, vitamin premix. selenium, copper sulfate. Culture was added at approximately 5×105 CFU/gm feed.
Conditioning temperature was 70"C and the pellets out of the dye were 78 °C.
Pellets were stored in unsealed bags and sampled weekly for CFU determination.
In each instance the pelletized product was not adversely affected in stability by the conditions of pelletizing. In particular, the pelletized product showed stability equal to the unpelletized product.
Example 5
Four thousand five hundred sixty, day-old
Peterson x Arbor Acres broiler chicks were randomly assigned to floor pens (Table 2) with reconditioned litter and fed for 45 days. All birds dying during the first 5 days were replaced with a same-sex bird from the same shipment and same treatment. The composition of the basal starter, grower, and
withdrawal rations is shown in Table 3. Starter, grower, and withdrawal rations were formulated to contain 1425, 1450, and 1475 kcal ME/lb, respectively, with 90 g/ton monesin. Starter rations were fed from 1 to 21 days of age, grower from 21 to 42 days of age, and withdrawal from 42 to 49 days of age. The
treatments were negative control, mash ( Control, M) ; a selected, encapsulated direct-fed microbial cultures containing Enterococcus faecium 301, DSM No. DSM-Nr. 4789 and Enterococcus faecium 202, DSM No. DSM-Nr.
4788 each rotary disc fatty acid encapsulated as described in Example 1 and ed n. present as 50% of the direct-fed microbial applied at 1 × 105 CFU/g of feed, mash (direct-fed microbial, M); negative control, pelleted (Control, P); direct-fed microbial applied at 1 × 106 CFU/g mash, pelleted (direct-fed microbial, P); and a positive control applied at 10 g/ton
virginiamycin, pelleted (Stafac® 10). The starter ration was crumbled for the treatments that were pelleted. Twelve replicated pens of 35 males and 35 females were used with each experimental ration.
Body weights, feed consumption, and mortality after the first 5 days were recorded by pen. Feed conversion, adjusted feed conversion, and body-weight adjusted feed conversion were calculated for each pen.
All data were subjected to analysis variance and differences were determined using Fisher LSD.
Prior to the study, direct-fed microbial culture concentrate was extended with calcium carbonate. The theoretical counts for direct-fed microbial, M and direct-fed microbial, P were 1 × 108 and 2 × 109 CFU/g of product, respectively. An 11 g sample of each product was assayed in duplicate to determine actual product counts. Each sample was plated using the standard plating technique for encapsulated lactic acid bacteria.
A mixer test was conducted for each production phase. The test was designed to ensure that the direct-fed microbial was uniformly distributed at appropriate levels in the feed and that it survived pelleting. Each batch was sampled at the time of bagging with 4 equally spaced samples for the mash treatments and 10 equally spaced samples for the pelleted treatments (i.e. bags 1, 3, 5,..., 35, 37, and 39).
Alternate floor pens within a treatment had non-contaminated feed sampled during weeks 1 and 4; with the remaining pens sampled on weeks 2 and 6 during the feeding study.
An equal number of birds from each sex was sacrificed for the determination of individual breast, body and small intestinal weights, and small
intestinal length. Breast yield and intestinal weight and length ratios were calculated for each bird.
All data were subjected to a split-plot analysis of variance and differences were determined using contrast and estimate statements for the desired effects.
Sixty birds per treatment were transported to a university for a sensory taste panel evaluation.
Direct-fed microbial, regardless of processing, improved ( P< .05 ) feed conversion over the respective Control while increasing (P<.05) weight gain over the Control only in the mash feed (Table 4). The direct-fed microbial, P improved (P>.05) feed conversion over Stafac® 10 which was similar (P>.05) to Control, P.
The product was at its desired level and strain composition (Table 5).
Direct-fed microbial was uniformly distributed within the feed. Direct-fed microbial, M was at its desired level while direct-fed microbial, P was 1 to 1-1/2 log higher than desired for the starter and grower rations (Table 6). The high counts for direct-fed microbial, P were a result of overengineering of the product to ensure sufficient recovery of the organisms after pelleting.
The floor pen samples for the direct-fed
microbial, P corresponded closely with the counts from the mixer tests (Table 7). However, direct-fed microbial, M dropped 2 logs in weeks 4 and 6 in the grower and withdrawal mixes. Direct-fed microbial, M increased (P<.05) both breast weight and yield over the Control, M (Table 8) while direct-fed microbial, P showed an improvement (P>.05) over Control, P. The improvement in the mash feed agrees with the results found in an earlier trial. The direct-fed microbial, P did not show a similar magnitude in improvement in breast yield to that observed in direct-fed microbial, M. This failure may be due to improved energy utilization by pelleting resulting in less room for improvement.
Pelleting increased the average bird weight by 96 g over mash. Direct-fed microbial increased the uniformity of bird weights (Figure 5) with the
greatest improvement is mash feed.
Pelleting increased the average breast weight by 15 g over mash. Direct-fed microbial increased the average breast weight and uniformity (Figure 4) over the Control with the greatest improvement found in mash. Stafac® 10 showed the greatest improvement in uniformity for the pelleted feeds.
Pelleting increased breast yeild by .53
percentage units over mash. Direct-fed microbial, M showed a .84 percentage unit increase over Control, M which was similar in magnitude to the pelleting respoonse.
The direct-fed microbial treatments produced a shorter (P>.05) small intestinal length than either of the Controls and Stafac ® when expressed as actual length, a ratio of either body weight, or breast weight (Table 9). Direct-fed microbial, M had a lighter (P>.05) small intestinal weight than Control, M when expressed as either actual weight or percentage of either body or breast weights. The reduction in intestinal weight and length for direct-fed microbial treatments suggests less energy required for
maintenance and more energy available for growth as indicated by improved feed conversion and breast yield (Table 7-8).
The direct-fed microbial, P treated birds
produced no off-flavor when compared to Stafac® 10 (Table 10). In the second trial, direct-fed
microbial, P was perceived to have enhanced the flavor of the thigh/leg when compared to Control, P.
However, this enhancement of flavor was not observed in the first trial.
Figure imgf000022_0002
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000023_0002
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000025_0002
Figure imgf000026_0001
Figure imgf000026_0002
A broiler trial was conducted to determine the efficacy of direct-fed microbial in mash and pelleted feeds. Direct-fed microbial, regardless of
processing, improved (P<.05) feed conversion over the respective Control while increasing (P<.05) weight gain over the Control only in the mash feed. Direct-fed microbial, P improved (P>.05) feed conversion over Stafac® 10 which was similar (P>.05) to Control, P. Direct-fed microbial, M increased (P<.05) both breast weight and yield over Control, M while direct-fed microbial, P showed an improvement (P>.05) over
Control, P. Direct-fed microbial, P treated birds produced no off-flavors when compared to Stafac ® 10 treated.
Example 6
One hundred forty four, commingled feeder pigs
(average initial weight 41.5 1b) were randomly
assigned to slated-floor pens by weight and sex (Table
11) and fed for 119 days. The composition of the basal grower and finisher rations is shown in Table
12. Grower rations were fed until individual pens averaged 120 lb followed by the finisher until
slaughter. All diets contained Mecadox ® (50 g/t) up through 75 lb bodyweight followed by 100 g/t
chlortetracycline until 120 lb liveweight. The treatments were negative control (Control) and a selected, microsphered direct-fed microbial cultures applied at 1 × 104 cfu/g of feed. All rations were fed in mash form. Six replicated pens of 12 feeder pigs were used with each experimental ration.
Upon arrival at the research facility, the commingled feeder pigs were given Ivomec ® to control internal and external parasites. Safeguard ® was given after four weeks to control whipworms. Body weights, feed consumption, and mortality were recorded by pen. Feed conversion was calculated for each pen.
Prior to the study, the microsphere culture concentrate was extended with calcium carbonate. The theoretical count was 2 × 107 cfu/g of product. An 11 g sample of product was assayed in duplicate to determine actual product counts. The sample was plated using standard plating technique for
microsphered lactic acid bacteria.
An additional 1 g sample of product was assayed in duplicate to verify the product count and strain composition.
Samples were taken for each treatment weekly and tested for microsphered lactic acid bacteria.
The product was confirmed as at its desired organism level (Table 14).
Pen sample recoveries varied from 1 × 101 to 1.6 × 105 cfu/g of feed (Table 15). The two extreme samples are attributed to sampling/plating error. The remainder of the samples averaged around the target level of 1 × 104 cfu/g of feed.
Microsphered product improved (P>.05) weight gain and feed conversion over the Control after 28 days
(Table 13). The pigs were hit with a TGE outbreak the first week of the trial. This outbreak along with time required for pig's digestive tract to adjust to the product may be why a 28 day lag was observed prior to an observed response. It can then be seen that the microsphere' s of direct-fed microbial of this
invention function effectively for swine as well as chickens and turkeys. From the above examples it can be seen that the invention accomplishes each of its stated objectives.
TABLE 11
PEN ASSIGNMENTS
Experiment: 670-9102
Treatments Pen numbers
Control 3, 4, 6, 9, 11, 12
Direct-fed microbial 1, 2, 5, 7, 8, 10
Pen size 4.6' x 16.0', one four-hole Smidley feeder, one nipple driker, sprinklers were used for heat control, partially-slated floor, and modified, open-front building.
Table 12
COMPOSITION OF BASAL RATIONS
Experiment: 670-9102
Ingredients Production phases
Grower Finisher
Ground corn 76.30 82.20
Soybean meal 21.25 15.50
Dicalcium phosphaste 1.05 .90
Calcium carbonate .85 .85
Salt .30 .30
Vitamin/mineral premix .25 .25
Figure imgf000030_0001
Figure imgf000031_0002
Figure imgf000031_0001
Table 15
FLOOR PEN QA
Experiment: 670-9102
Direct-Fed
Date Control Microbial
5/3/91 1.7 × 103 7.4 × 103
5/8/91 1.8 × 104 1.6 × 105
5/22/91 0 1.0 × 101
5/30/91 0 2.6 × 103
6/5/91 2.0 × 102 2.2 × 104
6/12/91 1.0 × 101 2.0 × 104
6/19/91 0 9.6 × 103
6/26/91 6.7 × 102 5.6 × 103
7/3/91 4.9 × 102 3.2 × 103
7/10/91 5.2 × 101 3.0 × 104
7/17/91 1.0 × 102 4.5 × 103
7/24/91 0 1.0 × 10 4
7/31/91 0 1.2 × 104
8/7/91 0 6.4 × 103
8/14/91 0 7.7 × 103
8/21/91 0 1.2 × 104
8/28/91 0 9.1 × 103
9/4/91 0 2.9 × 104
9/18/91 0 8.9 × 103
9/25/91 0 5.5 × 103
Mean 9.5 × 100 8.4 × 103

Claims

What is claimed is:
1.
A method of growth promotion animals comprising: adding to a normal animal feed ration a small but
growth promotion effective amount of direct-fed microbial consisting essentially of viable, stable, dried fatty acid microspheres of
Enterococcus faecium 301, ATCC No.
, and viable, stable, dried fatty
Figure imgf000033_0002
acid microspheres of Enterococcus faecium 202,
ATCC No.
Figure imgf000033_0001
.
2.
The method of claim 1 wherein the fatty acid spheres are formed using a rotary disc.
3.
The method of claim 2 wherein the direct-fed microbial is from about 30% to about 70% of one of said fatty acid microspheres with balance being the other.
4.
The method of claim 3 wherein the fatty acid is a C12 to C24 free fatty acid.
5.
The method of claim 4 wherein the fatty acid is stearic acid.
6.
The method of claim 1 wherein each of said streptococci are present in about equal amounts.
7.
The method of claim 1 wherein the amount of direct-fed microbial added to the feed ration is from about 0.5 pounds to about 2.0 lbs. /ton of feed.
8.
The method of claim 7 wherein the amount of direct-fed microbial is from about 0.8 lbs. to about 1.2 lbs./ton of feed.
9.
The method of claim 7 wherein the organism count of the direct-fed microbial is from about 1 × 105
CFU/gm to about 2 × 108 CFU/gm.
10.
The method of claim 9 wherein the organism count of the direct-fed microbial is about 1 × 105 CFU/gm.
11.
The process of claim 1 wherein the animal is a chicken.
12.
The process of claim 1 wherein the animal is swine.
13.
A direct-fed microbial composition for growth enhancement of animals swine consisting essentially of viable, stable, dried fatty acid microspheres of
Enterococcus faecium 301, and viable, stable, dried fatty acid microspheres of Enterococcus faecium 202.
14.
A direct-fed microbial of claim 13 which has from about 30% to about 20% of one of said streptococci with the balance being the other.
15.
The direct-fed microbial of claim 14 wherein the free fatty acid is a C12 to C24 free fatty acid.
16.
The direct-fed microbial of claim 15 wherein the free fatty acid stearic acid.
17.
The direct-fed microbial of claim 16 wherein the streptococci organisms are present in about equal amounts.
18.
The composition of claim 13 wherein the animal is a chicken.
19.
The composition of claim 13 wherein the animal is a swine.
PCT/US1993/000867 1992-03-17 1993-02-03 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality WO1993019162A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU94043791A RU2109052C1 (en) 1992-03-17 1993-02-03 Method and composition of microbial for direct nutrition for animal growth improvement
EP93904784A EP0631616A4 (en) 1992-03-17 1993-02-03 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality.
SK1116-94A SK111694A3 (en) 1992-03-17 1993-02-03 Fatty acid microspheres containing enteroccocus for use to enhance growth and improve meat quality
BR9306121A BR9306121A (en) 1992-03-17 1993-02-03 Microspheres of fatty acid containing enterococcus for use to improve growth and improve carcass quality
RO94-01518A RO112896B1 (en) 1992-03-17 1993-02-03 Direct microbial fodder composition for animal breeding and method for favouring its growth
BG99113A BG99113A (en) 1992-03-17 1994-10-17 Microspheres of fatty acids containing enterococcus accelerating the growth of animals and improving the quality of meat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85269292A 1992-03-17 1992-03-17
US07/852,692 1992-03-17

Publications (1)

Publication Number Publication Date
WO1993019162A1 true WO1993019162A1 (en) 1993-09-30

Family

ID=25313993

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/000867 WO1993019162A1 (en) 1992-03-17 1993-02-03 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality

Country Status (13)

Country Link
EP (1) EP0631616A4 (en)
JP (1) JP2849877B2 (en)
BG (1) BG99113A (en)
BR (1) BR9306121A (en)
CA (1) CA2131790A1 (en)
CZ (1) CZ225394A3 (en)
HU (1) HUT67965A (en)
MX (1) MX9301017A (en)
RO (1) RO112896B1 (en)
RU (1) RU2109052C1 (en)
SI (1) SI9300128A (en)
SK (1) SK111694A3 (en)
WO (1) WO1993019162A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628072A1 (en) * 1992-02-26 1994-12-14 Pioneer Hi-Bred International, Inc. Dried, rotary disc microspheres of microorganisms
WO1997045530A1 (en) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Use of streptococcus faecium strains and composition containing the same
WO2013114185A1 (en) * 2012-02-01 2013-08-08 Probiotical S.P.A. Multilayer microincapsulated probiotic bacteria
CN112843043A (en) * 2021-02-20 2021-05-28 华中农业大学 Application of salinomycin in preparing anti-coronavirus medicines

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003304444A1 (en) * 2003-08-26 2005-03-10 Zakrytoe Aktsionernoe Obschestvo "Alef" Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production
US4675140A (en) * 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292657A (en) * 1990-12-31 1994-03-08 Pioneer Hi-Bred International, Inc. Process for preparing rotary disc fatty acid microspheres of microorganisms
PL172912B1 (en) * 1990-12-31 1997-12-31 Pioneer Hi Bred Int Method of producing animal fodder additive in the form of fine capsules
SK278992B6 (en) * 1991-09-20 1998-05-06 Pioneer Hi-Bred International Probiotic mixture for supporting the growth of poultry

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production
US4675140A (en) * 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATCC Catalogue of Bacteria & Bacteriophages, 17th edition, 1989, page 79, see entire document. *
See also references of EP0631616A4 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0628072A1 (en) * 1992-02-26 1994-12-14 Pioneer Hi-Bred International, Inc. Dried, rotary disc microspheres of microorganisms
EP0628072A4 (en) * 1992-02-26 1995-12-20 Pioneer Hi Bred Int Dried, rotary disc microspheres of microorganisms.
WO1997045530A1 (en) * 1996-05-27 1997-12-04 UZILOVA, Irina Semenovna, Heiress of UZILOV Use of streptococcus faecium strains and composition containing the same
WO2013114185A1 (en) * 2012-02-01 2013-08-08 Probiotical S.P.A. Multilayer microincapsulated probiotic bacteria
US10738274B2 (en) 2012-02-01 2020-08-11 Probiotical North America Inc. Multilayer microencapsulated probiotic bacteria
CN112843043A (en) * 2021-02-20 2021-05-28 华中农业大学 Application of salinomycin in preparing anti-coronavirus medicines
CN112843043B (en) * 2021-02-20 2023-03-14 华中农业大学 Application of salinomycin in preparation of anti-coronavirus medicines

Also Published As

Publication number Publication date
RU2109052C1 (en) 1998-04-20
SK111694A3 (en) 1995-07-11
BR9306121A (en) 1998-01-13
RO112896B1 (en) 1998-01-30
CA2131790A1 (en) 1993-09-30
JP2849877B2 (en) 1999-01-27
RU94043791A (en) 1997-03-10
BG99113A (en) 1995-07-28
JPH07505056A (en) 1995-06-08
CZ225394A3 (en) 1995-01-18
EP0631616A1 (en) 1995-01-04
HUT67965A (en) 1995-05-29
EP0631616A4 (en) 1995-04-19
SI9300128A (en) 1993-09-30
MX9301017A (en) 1993-09-30
HU9402673D0 (en) 1994-11-28

Similar Documents

Publication Publication Date Title
EP1079703B1 (en) Use of a natural substance containing thymol in the manufacture of animal feed against clostridium sp
US9986750B2 (en) Animal feed compositions and feed additives
EP0628072A1 (en) Dried, rotary disc microspheres of microorganisms
WO2003043441A1 (en) Antimicrobial composition for animals
CN114747688A (en) &#39;four-in-one&#39; combined additive capable of improving intestinal functions of dogs and cats and preparation method thereof
EP0565522B1 (en) Dried, rotary disc fatty acid microencapsulated bacteria
WO1993019162A1 (en) Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality
RU2093571C1 (en) Method of stimulation of poultry growth and the probiotic-base preparation
CA1091502A (en) Feed composition containing ronnel and antibiotic a3823 complex or factor and use thereof
EP1143805B1 (en) Method for reducing incidence of ascites in poultry by aid of natamycin
US3719758A (en) Method of promoting growth and improving feed efficiency in poultry and swine via oral administration of cephalosporin c
EP0093271A1 (en) Growth promotion of monogastric animals
WEEKS et al. JC FRITZ, PB MISLIVEC, GW PLA, BN HARRISON

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): BG BR CA CZ HU JP PL RO RU SK

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
EX32 Extension under rule 32 effected after completion of technical preparation for international publication
WWE Wipo information: entry into national phase

Ref document number: 2131790

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PV1994-2253

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 111694

Country of ref document: SK

Ref document number: 94-01518

Country of ref document: RO

WWE Wipo information: entry into national phase

Ref document number: 1993904784

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993904784

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1994-2253

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: PV1994-2253

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1993904784

Country of ref document: EP